Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Avenzo Therapeutics, Inc.
Kivu Bioscience Inc.
National Cancer Institute, Egypt
Institut Claudius Regaud
Achieve Life Sciences
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of California, San Francisco
BioNTech SE
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
BeOne Medicines
BicycleTx Limited
MOMA Therapeutics
Astellas Pharma Inc
Kestrel Therapeutics, Inc.
Institut Claudius Regaud
Institut Claudius Regaud
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
National Cancer Institute, Naples
Hospices Civils de Lyon
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Edwards Lifesciences
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cancer Trials Ireland
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ascendis Pharma A/S
Hoffmann-La Roche
National Cancer Institute (NCI)
Icahn School of Medicine at Mount Sinai
National Cancer Institute (NCI)